Boothbay Fund Management’s Clene CLNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-719
Closed -$47.6K 2278
2022
Q2
$36K Sell
719
-1,745
-71% -$97.5K ﹤0.01% 2115
2022
Q1
$194K Hold
2,464
﹤0.01% 1896
2021
Q4
$202K Hold
2,464
﹤0.01% 1488
2021
Q3
$337K Buy
2,464
+1,800
+271% +$307K 0.01% 1267
2021
Q2
$149K Sell
664
-183
-22% -$38.6K ﹤0.01% 1639
2021
Q1
$216K Buy
847
+306
+57% +$67.1K 0.01% 1332
2020
Q4
$98K Buy
+541
New +$119K ﹤0.01% 1184
2020
Q2
Sell
-6,250
Closed -$1.31M 990
2020
Q1
$1.31M Hold
6,250
0.11% 237
2019
Q4
$1.32M Sell
6,250
-13,750
-69% -$2.86M 0.11% 246
2019
Q3
$4.12M Buy
+20,000
New +$4.11M 0.38% 49
2018
Q4
Sell
-16,250
Closed -$3.15M 692
2018
Q3
$3.15M Buy
+16,250
New +$3.14M 0.31% 68

Other funds holding CLNN

Boothbay Fund Management's CLNN Position: Q3 2022 in Review

Boothbay Fund Management sold out of Clene (CLNN) in Q3 2022, closing a stake of 719 shares — an estimated $47.6K sold.

Boothbay Fund Management first reported a position in CLNN in Q3 2018 and held it in 11 quarters. The position peaked at $4.12M in Q3 2019. 38 funds tracked by Wall St. Rank hold CLNN as of Q3 2022.

  • Boothbay Fund Management reported no remaining Clene position as of Q3 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 719 Clene shares in Q3 2022, an estimated $47.6K.
  • Boothbay Fund Management first reported a position in Clene in Q3 2018 and held it in 11 quarters.
  • Boothbay Fund Management's Clene position peaked at $4.12M in Q3 2019.
  • 38 funds tracked by Wall St. Rank held Clene as of Q3 2022.

Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.